BARCLAYS PLC - BLACK DIAMOND THERAPEUTICS I ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$925
+47.3%
322,246
+159.1%
0.00%
Q2 2023$628
+1597.3%
124,351
+542.6%
0.00%
Q1 2023$37
+5.7%
19,3510.0%0.00%
Q4 2022$35
-99.9%
19,351
-7.6%
0.00%
Q3 2022$35,000
-35.2%
20,935
-4.8%
0.00%
Q2 2022$54,000
-26.0%
21,992
-16.6%
0.00%
Q1 2022$73,00026,3800.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q4 2023
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$86,074,0004.50%
Boxer Capital, LLC 2,014,858$50,271,0003.43%
RA Capital Management 2,589,904$64,618,0002.04%
Artal Group S.A. 1,696,517$42,328,0001.79%
Logos Global Management LP 123,465$2,772,0001.05%
BVF INC/IL 378,788$9,451,0000.88%
Casdin Capital, LLC 289,395$7,220,0000.77%
Perceptive Advisors 1,104,656$27,561,0000.72%
Bellevue Group AG 1,330,000$33,184,0000.64%
Vivo Capital, LLC 252,119$6,290,0000.57%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders